Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
An open-label randomized Phase II study in order to explore two different sequential
anthracycline-based neoadjuvant treatment regimens in female patients with primary, operable
breast cancer (T2-T4/N0-2/M0).